挪威南部巨细胞动脉炎发病率趋势与死亡率
基于挪威南部近30万 homogeneous 人群,2000–2013年共纳入206例巨细胞动脉炎(GCA)患者,女性占72%。年龄≥50岁人群年发病率为16.8/10万(95%CI 14.6–19.2),女性24.5、男性10.2;总标准化死亡比为1.05(95%CI 0.77–1.38),未见超额死亡,但男性生存率显著低于女性(P<0.001)。
要点
- GCA年发病率未呈上升趋势,≥50岁人群为16.8/10万。
- 总标准化死亡比1.05(95%CI 0.77–1.38),未发现超额死亡。
- 男性生存率显著低于女性(P<0.001)。
核心结论
- 挪威南部2000–2013年GCA发病率未增加,未发现超额死亡,但男性生存率较女性差。
研究设计与样本
- 纳入标准为符合ACR 1990年GCA分类标准、组织学证实GCA或影像学证实大/中等血管炎。
- 共纳入206例患者,女性147例(72%),随访14年评估死亡率。
主要发现
- ≥50岁人群GCA年发病率为16.8/10万(95%CI 14.6–19.2),女性24.5/10万(95%CI 19.2–26.5),男性10.2/10万(95%CI 7.9–13.2)。
- 总标准化死亡比为1.05(95%CI 0.77–1.38),女性0.92(95%CI 0.61–1.35),男性1.38(95%CI 0.88–2.05)。
- 女性总体生存率显著高于男性(P<0.001)。
关键数值与推荐
- GCA诊断采用ACR 1990年分类标准、组织学证实或影像学证实大/中等血管炎。
- 发病率以每10万≥50岁居民年发病数表示。
- 死亡率以标准化死亡比(SMR)及95%CI表示。
临床怎么用
- 临床可参考该人群GCA发病率数据用于流行病学评估,但需注意男性患者可能预后更差。
- 对GCA患者应关注性别差异对生存的影响,男性患者或需更密切随访。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Southern Norway consists of a homogeneous population of nearly 300,000 inhabitants and is an ideal epidemiologic setting. We aimed to explore potential changes in incidence of giant cell arteritis (GCA) in Southern Norway from 2000-2013, with comparisons of previous reports from the same population cohort from 1987-1994 and 1992-1996, and to investigate the mortality rates of GCA over a period of 14 years. METHODS: All patients diagnosed with GCA during January 1, 2000 to December 31, 2013 were identified through the electronic health records and biopsy findings databases at our clinic. The diagnosis of GCA and information about death was confirmed by reviewing the patients' hospital records. Inclusion criteria were: 1) fulfillment of the American College of Rheumatology 1990 criteria for GCA, or 2) histologically proven GCA, or 3) confirmed arteritis of the large or medium-sized vessels by imaging. RESULTS: A total of 206 patients were included, and 147 (72%) were females. The annual incidence rate of GCA per 100,000 inhabitants age ≥50 years was 16.8 (95% confidence interval [95% CI] 14.6-19.2), 24.5 for females (95% CI 19.2-26.5), and 10.2 for males (95% CI 7.9-13.2). Forty-six patients (22%) died (24 women, 22 men). The overall standardized mortality ratio was 1.05 (95% CI 0.77-1.38), 0.92 for females (95% CI 0.61-1.35), and 1.38 for males (95% CI 0.88-2.05). Overall survival rate was significantly higher in females compared to males (P < 0.001). CONCLUSION: GCA incidence is not increasing. We did not find excess mortality; however, males seem to have a worse survival rate compared to females.
引用
- Andersen JB, Myklebust G, Haugeberg G, et al. Incidence Trends and Mortality of Giant Cell Arteritis in Southern Norway. Arthritis Care Res (Hoboken). 2021. PMID: 31909871. doi:10.1002/acr.24133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。